Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Recruiting

Registered drugNo placebo

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Small cell lung cancer

Recruiting

Registered drugNo placebo

Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Topotecan

Contact Research Centre

Squamous cell carcinoma of lung+2

Recruiting

Registered drugNo placebo

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Anaemia of chronic disease

Recruiting

Registered drugNo placebo

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Darbepoetin Alfa

Contact Research Centre

Clostridium difficile infection

Recruiting

Investigational

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Investigational

Romania

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live

Contact Research Centre

Psychotic disorder+1

Recruiting

InvestigationalNo placebo

Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis

InvestigationalNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Neoplasm malignant

Recruiting

Registered drugNo placebo

Study of BI-1206 and Pembrolizumab for Patients with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Hormone-refractory prostate cancer

Recruiting

Registered drugNo placebo

Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drug

Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Mk-1084

Contact Research Centre

Myelofibrosis+1

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Aprepitant

Contact Research Centre

Non-small cell lung cancer+2

Recruiting

Registered drugNo placebo

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Cemiplimab

Contact Research Centre

Breast cancer+2

Recruiting

Registered drugNo placebo

Long-term Safety Study of Niraparib for Patients with Advanced Ovarian, Breast, or Prostate Cancer Who Completed a Previous Niraparib Study

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Niraparib Tosilate Monohydrate

Contact Research Centre

Find therapies in clinical trials near you – page 9

316 trials match your criteria

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Small cell lung cancer

Study on Ifinatamab Deruxtecan and Topotecan for Patients with Relapsed Small Cell Lung Cancer

Squamous cell carcinoma of lung+2

Study Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance

Anaemia of chronic disease

Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

Clostridium difficile infection

Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

Psychotic disorder+1

Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis

Neoplasm malignant

Study of BI-1206 and Pembrolizumab for Patients with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1 Therapy

Hormone-refractory prostate cancer

Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

Non-small cell lung cancer

Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

Myelofibrosis+1

Study on the Effectiveness and Safety of Selinexor for Patients with Myelofibrosis and Moderate Thrombocytopenia Who Have Not Used JAK Inhibitors

Non-small cell lung cancer+2

Study on THIO and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer

Breast cancer+2

Long-term Safety Study of Niraparib for Patients with Advanced Ovarian, Breast, or Prostate Cancer Who Completed a Previous Niraparib Study

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.